"A Synexus rendelők klinikai kutatásokra szakosodott vizsgálóhelyek, amelyek már több mint 20 éve vizsgálják az új gyógyszerek és kezelések hatékonyságát. Barátságos, nyugodt környezetet biztosítunk, ahol közösen hozzájárulhatunk Ön és mások egészségi állapotának javulásához, valamint a jövő nemzedék gyógyszereinek megszületéséhez. Jelenleg négy saját rendelőnk és két partneri vizsgálóhelyünk van Magyarországon, és további 34 saját klinikánk szerte a világon. Mindegyik magasan képzett orvosi és nővéri csapattal rendelkezik, hogy biztosítsuk betegeink számára a legmagasabb kényelmet és a professzionalizmust, mely általában megtalálható a magán egészségügyi szolgáltatásban."

During the past decade, Synexus Magyarország Kft. conducted 25 clinical trials. In the 10-year time frame, 25 clinical trials started and 26 clinical trials were completed, i.e. on average, 104% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 12 clinical trials were completed. i.e. 240% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Synexus Magyarország Kft." #1 sponsor was "Pfizer" with 12 trials, followed by "Gilead Sciences" with 4 trials sponsored, "Amgen" with 3 trials sponsored, "Boehringer Ingelheim" with 3 trials sponsored and "Bristol-Myers Squibb" with 3 trials sponsored. Other sponsors include 21 different institutions and companies that sponsored additional 25 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Synexus Magyarország Kft." #1 collaborator was "Brigham and Women's Hospital" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "Galapagos NV" with 1 trials as a collaborator, "ICON plc" with 1 trials as a collaborator and "Medidata Solutions" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Synexus Magyarország Kft." are "Psoriasis" (6 trials), "Psoriatic Arthritis" (4 trials), "Crohn's Disease" (3 trials), "Diabetes Mellitus, Type 2" (3 trials) and "Type 2 Diabetes Mellitus" (3 trials). Many other conditions were trialed in "Synexus Magyarország Kft." in a lesser frequency.

Most popular intervention types in "Synexus Magyarország Kft." are "Drug" (48 trials), "Behavioral" (3 trials), "Other" (3 trials), "Biological" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (24 trials), "CP-690,550" (3 trials), "Diet" (3 trials), "Exercise" (3 trials) and "Ranolazine" (3 trials). Other intervention names were less common.

The vast majority of trials in "Synexus Magyarország Kft." are 47 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Synexus Magyarország Kft.". undefined are not yet recruiting, 1 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 36 completed trials in Synexus Magyarország Kft., undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Synexus Magyarország Kft., 0 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 36 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 0 trials that are defined as “Not Applicable".